TokenPost·
Argus Moves Abbott to Hold After 2026 Sales Outlook Cut
Abbott’s revised full-year sales target followed 7% comparable-sales growth in the third quarter, while its adjusted earnings midpoint stayed unchanged.
More news
- TokenPostChugai Pharmaceutical Posts ¥228.07 IFRS EPS for Nine Months
- TokenPostBrent Crude Moves Above $116 With a 1.3% 24-Hour Gain
- TokenPostXRP Addresses Holding 1,000 to 100,000 Tokens Reach Record 1.14M
- TokenPostHonda Warns U.S. Auto Sector of Risk From Canada Tariff Hike
- TokenPostMeme Sector Leads Crypto Gains as AI Sector Falls 6.69%
- TokenPostCoinShares Publishes Oct. 27 Edition of Its Digital Asset Digest